Ulrike Steffen

1.6k total citations
22 papers, 687 citations indexed

About

Ulrike Steffen is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Ulrike Steffen has authored 22 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Ulrike Steffen's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Bone Metabolism and Diseases (5 papers). Ulrike Steffen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Bone Metabolism and Diseases (5 papers). Ulrike Steffen collaborates with scholars based in Germany, Austria and United States. Ulrike Steffen's co-authors include Georg Schett, Maria Sokolova, Aline Bözec, Gerhard Krönke, Daniela Weidner, Darja Andreev, Fabian T. Andes, Koray Taşçılar, Holger Bang and Arnd Kleyer and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Annals of Oncology.

In The Last Decade

Ulrike Steffen

20 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Steffen Germany 12 314 211 163 112 89 22 687
Shiva Arami United States 16 286 0.9× 236 1.1× 391 2.4× 184 1.6× 36 0.4× 19 951
Simon Chatfield Australia 12 456 1.5× 122 0.6× 309 1.9× 58 0.5× 39 0.4× 14 798
Darja Andreev Germany 13 264 0.8× 195 0.9× 253 1.6× 141 1.3× 15 0.2× 22 690
Jianping Guo China 18 320 1.0× 322 1.5× 357 2.2× 120 1.1× 13 0.1× 50 964
Tsuyoshi Kobashigawa Japan 14 311 1.0× 340 1.6× 378 2.3× 206 1.8× 16 0.2× 39 855
Jessica McHugh United States 9 176 0.6× 217 1.0× 202 1.2× 70 0.6× 21 0.2× 126 533
Davide Raineri Italy 13 372 1.2× 235 1.1× 172 1.1× 117 1.0× 159 1.8× 26 821
Adriana Cifù Italy 12 332 1.1× 106 0.5× 113 0.7× 28 0.3× 79 0.9× 28 620
I‐Tsu Chyuan Taiwan 17 242 0.8× 162 0.8× 337 2.1× 150 1.3× 24 0.3× 27 741
Yingni Li China 13 184 0.6× 199 0.9× 337 2.1× 92 0.8× 16 0.2× 34 637

Countries citing papers authored by Ulrike Steffen

Since Specialization
Citations

This map shows the geographic impact of Ulrike Steffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Steffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Steffen more than expected).

Fields of papers citing papers by Ulrike Steffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Steffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Steffen. The network helps show where Ulrike Steffen may publish in the future.

Co-authorship network of co-authors of Ulrike Steffen

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Steffen. A scholar is included among the top collaborators of Ulrike Steffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Steffen. Ulrike Steffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steffen, Ulrike, Daniela Sieghart, & G Steiner. (2025). Rheumatoid factor and anti-citrullinated protein IgA antibodies in the diagnosis, prognosis and monitoring of patients with rheumatoid arthritis. Journal of Translational Autoimmunity. 11. 100332–100332.
2.
Sokolova, Maria, F Hartmann, Daniela Sieghart, et al.. (2023). Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk. RMD Open. 9(1). e002705–e002705. 8 indexed citations
3.
Mahajan, Aparna, Daniela Weidner, Rostyslav Bilyy, et al.. (2023). Suppression of neutrophils by sodium exacerbates oxidative stress and arthritis. Frontiers in Immunology. 14. 1174537–1174537. 5 indexed citations
4.
Steffen, Ulrike, et al.. (2023). IgA2 immune complexes selectively promote inflammation by human CD103+ dendritic cells. Frontiers in Immunology. 14. 1116435–1116435. 8 indexed citations
5.
Unterweger, Harald, et al.. (2022). IgA Complexes Induce Neutrophil Extracellular Trap Formation More Potently Than IgG Complexes. Frontiers in Immunology. 12. 761816–761816. 29 indexed citations
6.
Rodríguez-Fernández, Silvia, Katerina Kachler, Darja Andreev, et al.. (2022). A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine Nanotechnology Biology and Medicine. 48. 102635–102635. 15 indexed citations
7.
Sokolova, Maria, Georg Schett, & Ulrike Steffen. (2021). Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings. Clinical Reviews in Allergy & Immunology. 63(2). 138–151. 75 indexed citations
8.
Knopf, Jasmin, Aylin Lindemann, Julia Fürst, et al.. (2020). IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients. Cells. 9(12). 2676–2676. 28 indexed citations
9.
Hagelkrüys, Astrid, Gerald Wirnsberger, Johannes Stadlmann, et al.. (2020). A crucial role for Jagunal homolog 1 in humoral immunity and antibody glycosylation in mice and humans. The Journal of Experimental Medicine. 218(1). 15 indexed citations
10.
Andreev, Darja, Daniela Weidner, Katerina Kachler, et al.. (2020). Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin. Journal of Clinical Investigation. 130(9). 4811–4830. 127 indexed citations
11.
Vergarajauregui, Silvia, Robert Becker, Ulrike Steffen, et al.. (2020). AKAP6 orchestrates the nuclear envelope microtubule-organizing center by linking golgi and nucleus via AKAP9. eLife. 9. 36 indexed citations
12.
Andes, Fabian T., Susanne Adam, Madelaine Hahn, et al.. (2020). The human sialic acid-binding immunoglobulin-like lectin Siglec-9 and its murine homolog Siglec-E control osteoclast activity and bone resorption. Bone. 143. 115665–115665. 12 indexed citations
13.
Bang, Holger, Melanie Hagen, Michael Frech, et al.. (2019). The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study. Nutrients. 11(10). 2392–2392. 100 indexed citations
14.
Steffen, Ulrike, Georg Schett, & Aline Bözec. (2019). How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis. Frontiers in Immunology. 10. 1483–1483. 67 indexed citations
15.
Adam, Susanne, Ulrike Steffen, Fabian T. Andes, et al.. (2019). OP0076 JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO. Annals of the Rheumatic Diseases. 78. 110–110.
16.
Steffen, Ulrike, Fabian T. Andes, & Georg Schett. (2019). Generation and Analysis of Human and Murine Osteoclasts. Current Protocols in Immunology. 125(1). e74–e74. 10 indexed citations
17.
Adam, Susanne, Ulrike Steffen, Fabian T. Andes, et al.. (2019). P148 JAK-inhibition by baricitinib and tofacitinib ameliorates pathological bone loss. Annals of the Rheumatic Diseases. 78. A65–A65. 1 indexed citations
18.
Faehling, Martin, Johannes Achenbach, Peter Staib, et al.. (2018). Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC). Journal of Cancer Research and Clinical Oncology. 144(7). 1375–1383. 11 indexed citations
19.
Faehling, Martin, et al.. (2016). Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC). Annals of Oncology. 27. vi437–vi437. 3 indexed citations
20.
Steffen, Ulrike, et al.. (1970). [The management of pain with imipramine in cancer].. PubMed. 65(5). 213–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiva Arami Breakdown of academic impact, for papers by Simon Chatfield Breakdown of academic impact, for papers by Darja Andreev Breakdown of academic impact, for papers by Jianping Guo Breakdown of academic impact, for papers by Tsuyoshi Kobashigawa Breakdown of academic impact, for papers by Jessica McHugh Breakdown of academic impact, for papers by Davide Raineri Breakdown of academic impact, for papers by Adriana Cifù Breakdown of academic impact, for papers by I‐Tsu Chyuan Breakdown of academic impact, for papers by Yingni Li
Rankless by CCL
2026